Investigational Site Number 616004

Lublin 20-607

0 studies enrolling now · 3 studies all time

What they study most

Ankylosing Spondylitis, Relapsing-remitting Multiple Sclerosis

Studies at this site

• Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis — Completed
• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early
• Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839 — Stopped early